AdventHealth Cancer Institute diagnoses approximately 30,000 cancer cases annually, representing 20% of Florida’s estimated 145,000 annual cancer cases. In Central Florida, one in every two patients with cancer have cancer surgery at AdventHealth. The Cancer Institute has 17 cancer centers, with two more planned, 12 disease-site and subspecialty oncology programs, and more than 300 oncology providers. The program is ranked No. 1 for cancer care in the greater Orlando area by U.S. News & World Report. It offers over 250 oncology clinical trials, including 25 phase 1 studies, and 112 dedicated research employees, including principal investigators and research staff. AdventHealth is expanding quaternary cancer care with a new Central Florida cancer flagship, since an estimated one in five residents in the region require quaternary cancer care, which is the highest, most acute level of care. It is also home to the only Lymphatic Education & Research Network center of national excellence in the Southeast. AdventHealth leads the market in inpatient and outpatient cancer surgeries, and is Central Florida’s first and only blood and marrow transplant program. The program also reports some of the best outcomes in the nation for treating leukemia, lymphoma, myeloma and more. It is also one of the most active lung and esophageal clinical trial sites in the country. Its gynecological, brain and spine cancer programs are also among the top in the nation, with outcomes that exceed averages. Recent clinical milestones include performing a liver transplant for metastatic colon cancer and lymphatic bypass surgery.
